Cargando…
Inclusion of patient-reported outcome instruments in US FDA medical device marketing authorizations
BACKGROUND: The U.S. Food and Drug Administration encourages the incorporation of the patient voice throughout the medical device total product lifecycle. This study examined the incorporation of patient-reported outcome (PRO) instruments in the evaluation of medical devices over a six-year period....
Autores principales: | Matts, Sophia T., Webber, Christina M., Bocell, Fraser D., Caldwell, Brittany, Chen, Allen L., Tarver, Michelle E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021347/ https://www.ncbi.nlm.nih.gov/pubmed/35441987 http://dx.doi.org/10.1186/s41687-022-00444-z |
Ejemplares similares
-
Patient-reported outcomes and medical device evaluation: from conception to implementation
por: Webber, Christina M., et al.
Publicado: (2022) -
IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers
por: Berg, Carla J., et al.
Publicado: (2021) -
Public perceptions of the FDA’s marketing authorization of Vuse on Twitter/X
por: Lee, Sarah, et al.
Publicado: (2023) -
First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization
por: Fortner, Andra, et al.
Publicado: (2021) -
Menstrual tampons and vaginal pessaries: regulation of intravaginal medical devices by the US FDA
por: Pollard, Colin M.
Publicado: (2023)